Concepedia

Publication | Closed Access

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

DOI

253

Citations

26

References

2017

Year

Simon Bowman, Colin Everett, John O’Dwyer, Paul Emery, Costantino Pitzalis, Wan‐Fai Ng, Colin Pease, Elizabeth Price, Nurhan Sutcliffe, Nagui Gendi,
Arthritis & Rheumatology

Abstract

The results of this study indicate that rituximab is neither clinically effective nor cost-effective in this patient population.

References

YearCitations

Page 1